Search research articles
Contact Us
Filters
Showing results (41-50 of 64) with videos related to
Page
of 7
Sort By:
Cancer Chemotherapy and Pharmacology
|
November 30, 2013
E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
Taofeek K Owonikoko, Joseph Aisner, Xin Victoria Wang, et al.
Cancer Chemotherapy and Pharmacology
|
March 28, 2020
Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer
Hani M Babiker, Mohammed Milhem, Joseph Aisner, et al.
Cancer Chemotherapy and Pharmacology
|
February 10, 2020
Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer
Hani M Babiker, Mohammed Milhem, Joseph Aisner, et al.
Investigational New Drugs
|
August 8, 2019
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors
Mark N Stein, Susan Goodin, Murugeson Gounder, et al.
Anti-Cancer Drugs
|
May 6, 2008
Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia
Biren Saraiya, Murugesan Gounder, Jayeeta Dutta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2002
Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate
Roger K Strair, Dale Schaar, Lauri Goodell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
Nuclear factor-kappaB modulation in patients undergoing induction chemotherapy for acute myelogenous leukemia
Roger K Strair, Mecide Gharibo, Dale Schaar, et al.
Annals of Translational Medicine
|
April 26, 2019
Clinical significance of pretreatment tumor growth rate for locally advanced non-small cell lung cancer
Benedict Osorio, Nikhil Yegya-Raman, Sinae Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer
Helen J Ross, George R Blumenschein, Joseph Aisner, et al.
JAMA Oncology
|
February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial
Salma K Jabbour, Abigail T Berman, Roy H Decker, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 64) with videos related to
Sort By:
Page
of 7
Cancer Chemotherapy and Pharmacology
|
November 30, 2013
E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
Taofeek K Owonikoko, Joseph Aisner, Xin Victoria Wang, et al.
Cancer Chemotherapy and Pharmacology
|
March 28, 2020
Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer
Hani M Babiker, Mohammed Milhem, Joseph Aisner, et al.
Cancer Chemotherapy and Pharmacology
|
February 10, 2020
Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer
Hani M Babiker, Mohammed Milhem, Joseph Aisner, et al.
Investigational New Drugs
|
August 8, 2019
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors
Mark N Stein, Susan Goodin, Murugeson Gounder, et al.
Anti-Cancer Drugs
|
May 6, 2008
Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia
Biren Saraiya, Murugesan Gounder, Jayeeta Dutta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2002
Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate
Roger K Strair, Dale Schaar, Lauri Goodell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
Nuclear factor-kappaB modulation in patients undergoing induction chemotherapy for acute myelogenous leukemia
Roger K Strair, Mecide Gharibo, Dale Schaar, et al.
Annals of Translational Medicine
|
April 26, 2019
Clinical significance of pretreatment tumor growth rate for locally advanced non-small cell lung cancer
Benedict Osorio, Nikhil Yegya-Raman, Sinae Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer
Helen J Ross, George R Blumenschein, Joseph Aisner, et al.
JAMA Oncology
|
February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial
Salma K Jabbour, Abigail T Berman, Roy H Decker, et al.
Page
of 7